QA: Balchem CORP in us_medicinal_products/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2025_Balchem_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, Balchem CORP

  xvar xval
0 LiabilitiesNoncurrent 12,967,000
1 LiabilitiesCurrent 201,407,000
2 remainder_Liabilities 211,084,000
3 AssetsCurrent 313,770,000
4 AssetsNoncurrent 32,637,000
5 PropertyPlantAndEquipmentNet 282,154,000
6 Goodwill 945,080,000
7 remainder_Assets 1,730,000
8 GeneralAndAdministrativeExpense 753,982,000
9 ResearchAndDevelopmentExpense 16,793,000
10 remainder_Expenses 37,978,000
11 remainder_Revenues 953,684,000
12 remainder_NetIncome -16,456,000
13 remainder_ComprehensiveNetIncome -32,438,000
  yvar yval
0 Liabilities 425,458,000
1 Assets 1,575,371,000
2 Expenses 808,753,000
3 Revenues 953,684,000
4 StockholdersEquity 1,149,913,000
5 NetIncome 128,475,000
6 ComprehensiveNetIncome 112,256,000
7 BaseVar 1,906,080,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.69
9 EconomicCapitalRatio 2.14

Edgar->Model Mapping

Feature Distribution

Change over Time